These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 36966300)

  • 1. Recent advances in targeted therapies in acute myeloid leukemia.
    Bhansali RS; Pratz KW; Lai C
    J Hematol Oncol; 2023 Mar; 16(1):29. PubMed ID: 36966300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing paradigms in the treatment of acute myeloid leukemia in older patients.
    Bazinet A; Kadia TM
    Clin Adv Hematol Oncol; 2022 Jan; 20(1):37-46. PubMed ID: 35060961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Emerging Therapies for Acute Myeloid Leukemia.
    Ball B; Mei M; Otoukesh S; Stein A
    Cancer Treat Res; 2021; 181():57-73. PubMed ID: 34626355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Relapsed Acute Myeloid Leukemia.
    Thol F; Ganser A
    Curr Treat Options Oncol; 2020 Jun; 21(8):66. PubMed ID: 32601974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Therapy for Older Patients With Acute Myeloid Leukemia: How Should We Use Currently Available Agents?
    Kadia TM; Wei AH
    Cancer J; 2022 Jan-Feb 01; 28(1):67-72. PubMed ID: 35072376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
    Kantarjian HM; Kadia TM; DiNardo CD; Welch MA; Ravandi F
    Cancer; 2021 Apr; 127(8):1186-1207. PubMed ID: 33734442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
    Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
    Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Chen EC; Li S; Eisfeld AK; Luskin MR; Mims A; Jones D; Antin JH; Cutler CS; Koreth J; Ho VT; Gooptu M; Romee R; El-Jawahri A; McAfee SL; DeFilipp Z; Soiffer RJ; Chen YB; Fathi AT
    Transplant Cell Ther; 2021 Jun; 27(6):479.e1-479.e7. PubMed ID: 33840625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Management of Acute Myeloid Leukemia: A Review.
    Venugopal S; Sekeres MA
    JAMA Oncol; 2024 Oct; 10(10):1417-1425. PubMed ID: 39115831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?
    McCurdy SR; Luger SM
    Haematologica; 2021 Oct; 106(10):2544-2554. PubMed ID: 34320781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia.
    Stone RM; O'Donnell MR; Sekeres MA
    Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Treatment Options for Acute Myeloid Leukemia in 2019.
    Cerrano M; Itzykson R
    Curr Oncol Rep; 2019 Feb; 21(2):16. PubMed ID: 30715623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Treatment Options for Older Patients with Acute Myeloid Leukemia.
    Saxena K; Konopleva M
    Curr Treat Options Oncol; 2021 Mar; 22(5):39. PubMed ID: 33743079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia.
    Ma J; Ge Z
    Bosn J Basic Med Sci; 2021 Aug; 21(4):409-421. PubMed ID: 33577442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute Myeloid Leukemia - Update 2022].
    Rausch C; Hiddemann W; von Bergwelt-Baildon M; Spiekermann K; Herold T
    Dtsch Med Wochenschr; 2022 Sep; 147(17):1108-1114. PubMed ID: 36030783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.
    Lai C; Bhansali RS; Kuo EJ; Mannis G; Lin RJ
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e390018. PubMed ID: 37155946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.